0.14 USD
−71.01 K USD
0.00 USD
17.25 M
About Translational Development Acquisition Corp.
Sector
Industry
CEO
Michael B. Hoffman
Headquarters
New York
Founded
2022
ISIN
KYG9008W1050
FIGI
BBG01S83YQK5
Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Translational Development Acquisition Corp. stocks are traded under the ticker TDAC.
Yes, you can track Translational Development Acquisition Corp. financials in yearly and quarterly reports right on TradingView.
TDAC net income for the last quarter is 1.62 M USD, while the quarter before that showed 1.48 M USD of net income which accounts for 9.46% change. Track more Translational Development Acquisition Corp. financial stats to get the full picture.
No, TDAC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 9, 2025, the company has 2 employees. See our rating of the largest employees — is Translational Development Acquisition Corp. on this list?
Like other stocks, TDAC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Translational Development Acquisition Corp. stock right from TradingView charts — choose your broker and connect to your account.